App-Based exercise shows promise for Post-COVID recovery
NCT ID NCT05770505
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using an e-health tool to guide exercise can improve fitness and quality of life in adults who had COVID-19. Seventy-seven participants who struggled with physical activity after their infection were enrolled. The experimental group used the MIA Health app and a heart rate monitor to track exercise, while the control group received no follow-up. The study measured changes in cardiorespiratory fitness, lung function, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- exercise training guided by an e-health tool
- What this could lead to
- If it works, this could offer a simple, home-based way to help people recover fitness and quality of life after COVID-19.
- What could go wrong
- This is a small, completed feasibility study with only 77 participants, so results may not apply to everyone. The intervention is behavioral, not a drug, so benefits may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging,
Trondheim, 7006, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?